Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

King's College London clarifies details of inquiry into publications by Eysenck and Grossarth-Maticek.

Everall IP.

BMJ. 2019 Nov 18;367:l6493. doi: 10.1136/bmj.l6493. No abstract available.

PMID:
31740436
2.

Exploring Heterogeneity on the Wisconsin Card Sorting Test in Schizophrenia Spectrum Disorders: A Cluster Analytical Investigation.

Carruthers SP, Gurvich CT, Meyer D; Australian Schizophrenia Research Bank, Bousman C, Everall IP, Neill E, Pantelis C, Sumner PJ, Tan EJ, Thomas EHX, Van Rheenen TE, Rossell SL.

J Int Neuropsychol Soc. 2019 Aug;25(7):750-760. doi: 10.1017/S1355617719000420.

PMID:
31104647
3.

Blood and brain protein levels of ubiquitin-conjugating enzyme E2K (UBE2K) are elevated in individuals with schizophrenia.

Meiklejohn H, Mostaid MS, Luza S, Mancuso SG, Kang D, Atherton S, Rothmond DA, Weickert CS, Opazo CM, Pantelis C, Bush AI, Everall IP, Bousman CA.

J Psychiatr Res. 2019 Jun;113:51-57. doi: 10.1016/j.jpsychires.2019.03.005. Epub 2019 Mar 8.

PMID:
30901725
4.

Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia.

Bousman CA, Luza S, Mancuso SG, Kang D, Opazo CM, Mostaid MS, Cropley V, McGorry P, Shannon Weickert C, Pantelis C, Bush AI, Everall IP.

Sci Rep. 2019 Feb 19;9(1):2307. doi: 10.1038/s41598-019-38490-1.

5.

The effects of a muscarinic receptor 1 gene variant on executive and non-executive cognition in schizophrenia spectrum disorders.

Carruthers SP, Cropley V, Bousman C, Everall IP, Neill E, Pantelis C, Sumner PJ, Tan EJ; Australian Schizophrenia Research Bank, Bozaoglu K, Thomas EHX, Van Rheenen TE, Gurvich CT, Rossell SL.

Psychiatry Res. 2019 Mar;273:178-180. doi: 10.1016/j.psychres.2019.01.032. Epub 2019 Jan 11.

PMID:
30654302
6.

Systematic review and critical appraisal of child abuse measurement instruments.

Saini SM, Hoffmann CR, Pantelis C, Everall IP, Bousman CA.

Psychiatry Res. 2019 Feb;272:106-113. doi: 10.1016/j.psychres.2018.12.068. Epub 2018 Dec 13.

PMID:
30580133
7.

An Interleukin-1 beta (IL1B) haplotype linked with psychosis transition is associated with IL1B gene expression and brain structure.

Mostaid MS, Dimitrakopoulos S, Wannan C, Cropley V, Weickert CS, Everall IP, Pantelis C, Bousman CA.

Schizophr Res. 2019 Feb;204:201-205. doi: 10.1016/j.schres.2018.09.008. Epub 2018 Sep 14.

PMID:
30220520
8.

Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia.

Scarr E, Hopper S, Vos V, Seo MS, Everall IP, Aumann TD, Chana G, Dean B.

J Psychiatry Neurosci. 2018 Aug;43(5):338-346.

9.

Depression, fatigue and neurocognitive deficits in chronic hepatitis C.

Yeoh SW, Holmes ACN, Saling MM, Everall IP, Nicoll AJ.

Hepatol Int. 2018 Jul;12(4):294-304. doi: 10.1007/s12072-018-9879-5. Epub 2018 Jun 21. Review.

PMID:
29931590
10.

Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia.

Scarr E, Hopper S, Vos V, Seo MS, Everall IP, Aumann TD, Chana G, Dean B.

J Psychiatry Neurosci. 2018 May 30;43(4):170202. doi: 10.1503/jpn.170202. [Epub ahead of print]

11.

Decreased peripheral TNF alpha (TNF-α) mRNA expression in patients with treatment-resistant schizophrenia.

Mostaid MS, Pantelis C, Everall IP, Bousman CA.

Schizophr Res. 2018 Dec;202:387-388. doi: 10.1016/j.schres.2018.04.032. Epub 2018 Apr 26. No abstract available.

PMID:
29706448
12.

Graphene foam as a biocompatible scaffold for culturing human neurons.

D'Abaco GM, Mattei C, Nasr B, Hudson EJ, Alshawaf AJ, Chana G, Everall IP, Nayagam B, Dottori M, Skafidas E.

R Soc Open Sci. 2018 Mar 7;5(3):171364. doi: 10.1098/rsos.171364. eCollection 2018 Mar.

13.

Downregulation of plasma SELENBP1 protein in patients with recent-onset schizophrenia.

Chau EJ, Mostaid MS, Cropley V, McGorry P, Pantelis C, Bousman CA, Everall IP.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jul 13;85:1-6. doi: 10.1016/j.pnpbp.2018.03.010. Epub 2018 Mar 22.

PMID:
29577944
14.

Genetic variation in cytokine genes and risk for transition to psychosis among individuals at ultra-high risk.

Bousman CA, Lee TY, Kim M, Lee J, Mostaid MS, Bang M, An SK, Everall IP, Pantelis C, Kwon JS.

Schizophr Res. 2018 May;195:589-590. doi: 10.1016/j.schres.2017.08.040. Epub 2017 Sep 13. No abstract available.

PMID:
28916135
15.

Schizophrenia genetics in the genome-wide era: a review of Japanese studies.

Kanazawa T, Bousman CA, Liu C, Everall IP.

NPJ Schizophr. 2017 Aug 30;3(1):27. doi: 10.1038/s41537-017-0028-2. Review.

16.

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.

Di Biase MA, Zalesky A, O'keefe G, Laskaris L, Baune BT, Weickert CS, Olver J, McGorry PD, Amminger GP, Nelson B, Scott AM, Hickie I, Banati R, Turkheimer F, Yaqub M, Everall IP, Pantelis C, Cropley V.

Transl Psychiatry. 2017 Aug 29;7(8):e1225. doi: 10.1038/tp.2017.193.

17.

Neuregulin-1 (NRG1) polymorphisms linked with psychosis transition are associated with enlarged lateral ventricles and white matter disruption in schizophrenia.

Bousman CA, Cropley V, Klauser P, Hess JL, Pereira A, Idrizi R, Bruggemann J, Mostaid MS, Lenroot R, Weickert TW, Glatt SJ, Everall IP, Sundram S, Zalesky A, Weickert CS, Pantelis C.

Psychol Med. 2018 Apr;48(5):801-809. doi: 10.1017/S0033291717002173. Epub 2017 Aug 22.

PMID:
28826413
18.

Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk.

Saini SM, Mancuso SG, Mostaid MS, Liu C, Pantelis C, Everall IP, Bousman CA.

Transl Psychiatry. 2017 Aug 8;7(8):e1196. doi: 10.1038/tp.2017.172.

19.

Pathway-wide association study identifies five shared pathways associated with schizophrenia in three ancestral distinct populations.

Liu C, Bousman CA, Pantelis C, Skafidas E, Zhang D, Yue W, Everall IP.

Transl Psychiatry. 2017 Feb 21;7(2):e1037. doi: 10.1038/tp.2017.8.

20.

Meta-analysis reveals associations between genetic variation in the 5' and 3' regions of Neuregulin-1 and schizophrenia.

Mostaid MS, Mancuso SG, Liu C, Sundram S, Pantelis C, Everall IP, Bousman CA.

Transl Psychiatry. 2017 Jan 17;7(1):e1004. doi: 10.1038/tp.2016.279.

21.

High heterogeneity and low reliability in the diagnosis of major depression will impair the development of new drugs.

Lieblich SM, Castle DJ, Pantelis C, Hopwood M, Young AH, Everall IP.

BJPsych Open. 2015 Nov 17;1(2):e5-e7. eCollection 2015 Oct.

22.

Serotonin transporter polymorphism (5HTTLPR), severe childhood abuse and depressive symptom trajectories in adulthood.

Nguyen TB, Gunn JM, Potiriadis M, Everall IP, Bousman CA.

BJPsych Open. 2015 Sep 22;1(1):104-109. eCollection 2015 Jun.

23.

The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Moderates the Effects of Childhood Abuse on Severity of Depressive Symptoms in a Time-Dependent Manner.

Webb C, Gunn JM, Potiriadis M, Everall IP, Bousman CA.

Front Psychiatry. 2016 Aug 29;7:151. doi: 10.3389/fpsyt.2016.00151. eCollection 2016.

24.

The distribution of muscarinic M1 receptors in the human hippocampus.

Scarr E, Seo MS, Aumann TD, Chana G, Everall IP, Dean B.

J Chem Neuroanat. 2016 Nov;77:187-192. doi: 10.1016/j.jchemneu.2016.07.006. Epub 2016 Jul 18.

PMID:
27435807
25.

Increased cortical expression of the zinc transporter SLC39A12 suggests a breakdown in zinc cellular homeostasis as part of the pathophysiology of schizophrenia.

Scarr E, Udawela M, Greenough MA, Neo J, Suk Seo M, Money TT, Upadhyay A, Bush AI, Everall IP, Thomas EA, Dean B.

NPJ Schizophr. 2016 Mar 9;2:16002. doi: 10.1038/npjschz.2016.2. eCollection 2016.

26.

Neuregulin-1 and schizophrenia in the genome-wide association study era.

Mostaid MS, Lloyd D, Liberg B, Sundram S, Pereira A, Pantelis C, Karl T, Weickert CS, Everall IP, Bousman CA.

Neurosci Biobehav Rev. 2016 Sep;68:387-409. doi: 10.1016/j.neubiorev.2016.06.001. Epub 2016 Jun 6. Review.

PMID:
27283360
27.

Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning.

Bharti AR, Woods SP, Ellis RJ, Cherner M, Rosario D, Potter M, Heaton RK, Everall IP, Masliah E, Grant I, Letendre SL.

HIV AIDS (Auckl). 2016 Apr 29;8:93-9. doi: 10.2147/HIV.S93306. eCollection 2016.

28.

Polygenic phenotypic plasticity moderates the effects of severe childhood abuse on depressive symptom severity in adulthood: A 5-year prospective cohort study.

Bousman CA, Gunn JM, Potiriadis M, Everall IP.

World J Biol Psychiatry. 2017 Feb;18(1):75-81. doi: 10.3109/15622975.2016.1153710. Epub 2016 Apr 6.

PMID:
26878222
29.

Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue.

Lai CY, Lee SY, Scarr E, Yu YH, Lin YT, Liu CM, Hwang TJ, Hsieh MH, Liu CC, Chien YL, Udawela M, Gibbons AS, Everall IP, Hwu HG, Dean B, Chen WJ.

Transl Psychiatry. 2016 Jan 19;6:e717. doi: 10.1038/tp.2015.213.

30.

SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia.

Udawela M, Money TT, Neo J, Seo MS, Scarr E, Dean B, Everall IP.

Transl Psychiatry. 2015 Aug 4;5:e615. doi: 10.1038/tp.2015.108.

31.

RDoC: We should look before we leap.

Lieblich SM, Castle DJ, Everall IP.

Aust N Z J Psychiatry. 2015 Sep;49(9):770-1. doi: 10.1177/0004867415592956. Epub 2015 Jun 22. No abstract available.

PMID:
26101398
32.

Decreased expression of mGluR5 within the dorsolateral prefrontal cortex in autism and increased microglial number in mGluR5 knockout mice: Pathophysiological and neurobehavioral implications.

Chana G, Laskaris L, Pantelis C, Gillett P, Testa R, Zantomio D, Burrows EL, Hannan AJ, Everall IP, Skafidas E.

Brain Behav Immun. 2015 Oct;49:197-205. doi: 10.1016/j.bbi.2015.05.009. Epub 2015 Jun 5.

PMID:
26052099
33.

Inhibition of catechol-O-methyl transferase (COMT) by tolcapone restores reductions in microtubule-associated protein 2 (MAP2) and synaptophysin (SYP) following exposure of neuronal cells to neurotropic HIV.

Lee TT, Chana G, Gorry PR, Ellett A, Bousman CA, Churchill MJ, Gray LR, Everall IP.

J Neurovirol. 2015 Oct;21(5):535-43. doi: 10.1007/s13365-015-0354-y. Epub 2015 Jun 3.

34.

Typologies of positive psychotic symptoms in methamphetamine dependence.

Bousman CA, McKetin R, Burns R, Woods SP, Morgan EE, Atkinson JH, Everall IP, Grant I; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Am J Addict. 2015 Mar;24(2):94-7. doi: 10.1111/ajad.12160.

35.

Response to Robinson et al.

Skafidas E, Testa R, Zantomio D, Chana G, Everall IP, Pantelis C.

Mol Psychiatry. 2015 Jul;20(7):794. doi: 10.1038/mp.2015.15. Epub 2015 Mar 10. No abstract available.

PMID:
25754086
36.

G-protein β3 subunit genetic variation moderates five-year depressive symptom trajectories of primary care attendees.

Bousman CA, Potiriadis M, Everall IP, Gunn JM.

J Affect Disord. 2014 Aug;165:64-8. doi: 10.1016/j.jad.2014.04.044. Epub 2014 Apr 24.

PMID:
24882179
37.

Response to Belgard et al.

Skafidas E, Testa R, Zantomio D, Chana G, Everall IP, Pantelis C.

Mol Psychiatry. 2014 Apr;19(4):407-9. doi: 10.1038/mp.2013.186. Epub 2014 Jan 14. No abstract available. Erratum in: Mol Psychiatry. 2014 Jun;19(6):743-4.

38.

Negative Symptoms of Psychosis Correlate with Gene Expression of the Wnt/β-Catenin Signaling Pathway in Peripheral Blood.

Bousman CA, Glatt SJ, Chandler SD, Lohr J, Kremen WS, Tsuang MT, Everall IP.

Psychiatry J. 2013;2013:852930. doi: 10.1155/2013/852930. Epub 2013 Jan 1.

39.

Methylenetetrahydrofolate reductase (MTHFR) genetic variation and major depressive disorder prognosis: A five-year prospective cohort study of primary care attendees.

Bousman CA, Potiriadis M, Everall IP, Gunn JM.

Am J Med Genet B Neuropsychiatr Genet. 2014 Jan;165B(1):68-76. doi: 10.1002/ajmg.b.32209. Epub 2013 Oct 4.

PMID:
24123968
40.

Effects of neuregulin-1 genetic variation and depression symptom severity on longitudinal patterns of psychotic symptoms in primary care attendees.

Bousman CA, Potiriadis M, Everall IP, Gunn JM.

Am J Med Genet B Neuropsychiatr Genet. 2014 Jan;165B(1):62-7. doi: 10.1002/ajmg.b.32206. Epub 2013 Oct 4.

PMID:
24123921
41.

Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.

Chana G, Bousman CA, Money TT, Gibbons A, Gillett P, Dean B, Everall IP.

Front Cell Neurosci. 2013 Jun 26;7:95. doi: 10.3389/fncel.2013.00095. eCollection 2013.

42.

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis.

Bousman CA, Yung AR, Pantelis C, Ellis JA, Chavez RA, Nelson B, Lin A, Wood SJ, Amminger GP, Velakoulis D, McGorry PD, Everall IP, Foley DL.

Transl Psychiatry. 2013 Apr 30;3:e251. doi: 10.1038/tp.2013.23.

43.

The neuropsychiatric and neuropsychological features of chronic fatigue syndrome: revisiting the enigma.

Christley Y, Duffy T, Everall IP, Martin CR.

Curr Psychiatry Rep. 2013 Apr;15(4):353. doi: 10.1007/s11920-013-0353-8. Review.

PMID:
23440559
44.

The spatial relationship between neurons and astrocytes in HIV-associated dementia.

Roberts ES, Chana G, Nguyen TB, Perera G, Landau S, Rabe-Hesketh S, Glass JD, McArthur J, Everall IP.

J Neurovirol. 2013 Apr;19(2):123-30. doi: 10.1007/s13365-013-0149-y. Epub 2013 Feb 21.

PMID:
23430713
45.

Oestrogen alpha-receptor variant and two-year memory decline in midlife Australian women.

Bousman CA, Szoeke C, Chen K, Dennerstein L, Henderson VW, Everall IP.

Neuropsychobiology. 2012;66(4):259-65. doi: 10.1159/000341879. Epub 2012 Oct 31.

46.

Predicting the diagnosis of autism spectrum disorder using gene pathway analysis.

Skafidas E, Testa R, Zantomio D, Chana G, Everall IP, Pantelis C.

Mol Psychiatry. 2014 Apr;19(4):504-10. doi: 10.1038/mp.2012.126. Epub 2012 Sep 11.

47.

A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia.

Pérez-Santiago J, Diez-Alarcia R, Callado LF, Zhang JX, Chana G, White CH, Glatt SJ, Tsuang MT, Everall IP, Meana JJ, Woelk CH.

J Psychiatr Res. 2012 Nov;46(11):1464-74. doi: 10.1016/j.jpsychires.2012.08.005. Epub 2012 Sep 3.

PMID:
22954356
48.

Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders.

Dean B, Gibbons AS, Tawadros N, Brooks L, Everall IP, Scarr E.

Mol Psychiatry. 2013 Jul;18(7):767-73. doi: 10.1038/mp.2012.95. Epub 2012 Jul 17.

PMID:
22801413
49.

Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism.

Morgan JT, Chana G, Abramson I, Semendeferi K, Courchesne E, Everall IP.

Brain Res. 2012 May 25;1456:72-81. doi: 10.1016/j.brainres.2012.03.036. Epub 2012 Mar 23.

PMID:
22516109
50.

Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders.

Soontornniyomkij V, Everall IP, Moore DJ, Gouaux B, Tatro ET, Gospodarev V, Masliah E, Yin NS, Vinters HV, Achim CL.

J Neurovirol. 2012 Aug;18(4):313-22. doi: 10.1007/s13365-011-0076-8. Epub 2012 Jan 11.

Supplemental Content

Loading ...
Support Center